(Q38348441)

English

A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation

scientific article published on March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Tomoko Nanri

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Naokuni Uike

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Toshiro Kawakita

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Eisaku Iwanaga

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Hiroaki Mitsuya

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Norio Asou

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Genes, Chromosomes and Cancer

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

237-241

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating Cells

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22).

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

C/EBPalpha mutations in acute myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

AML patients with CEBPalpha mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutation of CEBPA in familial acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Disruption of differentiation in human cancer: AML shows the way.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FGCC.20734

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GCC.20734

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38348441&oldid=1755403724"